Obstructive Sleep Apnea (OSA) is a serious common sleep disorder needs life long care. OSA is caused by recurrent upper airway obstruction due to increased upper airway collapsibility during sleep. It is highly associated with obesity with several endocrine and metabolic diseases. Hypothyroidism may cause OSA, also linked with obesity. Obesity is also a risk factor for hypertension.This paper is presenting a case of obstructive sleep apnea with obesity, hypertension and hypothyroidism. A 35 years old male presented with the complaints of excessive day time sleepiness, loud snoring, fragmented sleep, apnea like attack, occasional morning headache. Whole night polysomnography was done and diagnosed as severe obstructive sleep apnea. At therapeutic part of polysomnography, he was treated with BiPAP.
Introduction:
Obstructive Sleep Apnea (OSA) is the most common sleep disorder. OSA presents with excessive daytime sleepiness, snoring predisposing to cardiac and accident related morbidity and mortality. 24% to 62% elderly people suffers with OSA and peak age is about 55 years 1 . Male sex has three times higher risk of sleep apnea 2, 3 . Obesity itself individually increases risk factor for OSA 4, 5 . Only 10% weight gain increases sleep apnea risk apparently 30% 6 . BMI (kg/m 2 ) is measured by following WHO guideline 7 . Day time sleepiness was subjectively assessed by Epworth Sleepiness scale. Higher the score indicates greater sleepiness 8 . Neck circumference and higher BMI are the most prominent predictor for OSA. Central fat deposition around the neck and abdomen increases risk factor for OSA 9 . Overnight polysomnography is Gold standard for diagnosis of apnea, where multiple physiologic parameter during sleep is recorded like EEG, EMG, EOG, ECG, Oronasal airflow and oxygen hemoglobin saturation. Complete cessation of airflow for at least 10 seconds is known as apnea. On the basis of effort to breath during the event said to be Obstructive, Central and Mixed apnea. Figure 1 shows different types of Apnea on the effort to breath in diaphragmatic excursions (middle row) in overnight polysomnography. Top row shows cessation of airflow and bottom row shows oxygen haemoglobin desaturation in central, obstructive and mixed varieties. 30% reduction of oronasal airflow along with 3% oxygen hemoglobin desaturation is called hypopnea. Severity of sleep apnea indicated by Apnea Hypopnea index (AHI) which is total number of Apnea Hypopnea per hour of sleep. 
Discussion:
Obstructive sleep apnea presents recurrent closure of upper airway along with oxygen desaturation during sleep. Several studies show that there is an association present between obstructive sleep apnea with other clinical presentation. Obesity, Hypertension and hypothyroidism have individual role on OSA. 40% moderately obese patients suffer from OSA 4 . In addition, OSA strongly contributes to obesity related hypertension due to sympathetic overactivity, metabolic and neuroendocrine abnormalities are involved 11, 12 . Hypoxia have direct adverse role on cardiac electrical activity which results in sympathetic vasoconstriction and raised blood pressure 12 .
Although this patient has normal echocardiography, but pulmonary hypertension is common in OSA. About 12%-34% OSA patients have pulmonary hypertension due to nocturnal intermittent hypoxia which aggravates precapillary pulmonary hypertension 13, 14 . About 25% to 80% OSA patients have hypothyroidism. Similar contributing factors are responsible for occurrance of OSA in hypothyroidism. Deposition of mucopolysaccharides in upper airway, decreased ventilatory reponse in upper airway and also obesity have the etiological relationship for the of OSA in hypothyroidism 15, 16 .
Positive Airway Pressure (PAP) is the treatment choice for mild, moderate and severe OSA. PAP is an effective treatment option for reduction of AHI also improving daytime sleepiness, sleep related quality of life. PAP device is used by nasal, oral and oronasal mask. Three different modes of PAP devices are available for management of OSA like CPAP, BiPAP and APAP 17 . Hypothyroism with obesity presented with OSA should be treated with overnight PAP therapy even after remission of signs of hypothyroidism 18 .
